News
This article was translated into English by Artificial Intelligence. You can read the original version in 🇩🇪 here.Bayer ...
Axios on MSN3d
Bayer CEO says 2025 key for future of Roundup in U.S.Bayer is fighting to keep the popular agricultural herbicide Roundup available for farmers in the U.S., but warned it could ...
Bayer CEO Bill Anderson takes the stage at the 2025 CNBC CEO Council Summit to talk to leaders about managing through ...
German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...
Given its past difficulties in ending the Roundup litigation in civil courts, the German drug and agriculture conglomerate is ...
Bayer A.G.'s stock is undervalued but faces risks with declining profits & regulatory pressures. Click for my updated look at ...
Bayer said on Monday it would shrink the Crop Science division's production, research and development activities in Germany, ...
The company said it will discontinue certain production activities at its Dormagen and Frankfurt am Main sites.
Seven years ago, two events set forth a domino effect culminating in Bayer leaders having a potential “tough decision” of whether or not the company will continue to manufacture its legacy ...
Berlin: Bayer has announced initiation of a Phase I clinical trial with BAY 3670549, an investigational highly selective ...
Bayer shares jumped after the company reported better-than-expected sales and adjusted earnings for the first quarter, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback